Maternal Tdap Vaccine May Lower Infant Pertussis
June 24, 2024
-
3 min
A recent study in the JAMA Pediatrics analyzed the impact of maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination on pertussis incidence in US infants. The study found that the introduction of maternal Tdap vaccination was associated with a significant reduction in pertussis incidence among infants younger than 2 months. The findings emphasize the importance of increasing Tdap vaccination uptake among pregnant women to further reduce pertussis rates in this vulnerable population.
1. Maternal Tdap vaccination reduced pertussis incidence in US infants under 2 months.2. No significant change in pertussis incidence in infants aged 6 to 12 months post-maternal Tdap vaccination.3. Study published in JAMA Pediatrics emphasized the importance of increasing Tdap vaccination uptake among pregnant women.4. Sensitivity analyses were conducted to ensure data robustness.5. Limitations include lack of maternal vaccination status at the individual level and incomplete vaccination history data in the surveillance system.
Listen Tab content
